CC
Commodore Capital LP
NEW YORK NY · SEC CIK 0001831942
$1.68B2026Q2 reported value
33Positions
68.2%Top 10 weight · largest 13.4%
4 / 8New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
TNGX New+$70.33M
EDIT New+$28.80M
EYPT Added+$25.38M
IFRX New+$16.35M
ASMB Added+$11.40M
2026Q2 top sells estimated at quarter-end value
SYRE Reduced-$94.60M
RLAY Reduced-$93.55M
NUVALENT INC Reduced-$90.60M
ALKS Reduced-$62.87M
KYMR Reduced-$57.34M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| RLAY | RELAY THERAPEUTICS INC | $224.52M | 13.37% | 12,000,000 | -5,000,000 | -29.4% | -$93.55M | Reduced |
| ELVN | ENLIVEN THERAPEUTICS INC | $166.21M | 9.90% | 3,275,000 | 0 | 0.0% | — | Unchanged |
| ALKS | ALKERMES PLC | $157.19M | 9.36% | 3,000,000 | -1,200,000 | -28.6% | -$62.87M | Reduced |
| COGT | COGENT BIOSCIENCES INC | $118.03M | 7.03% | 3,050,000 | 161,993 | 5.6% | $6.27M | Added |
| AMLX | AMYLYX PHARMACEUTICALS INC | $101.47M | 6.04% | 5,650,000 | 0 | 0.0% | — | Unchanged |
| DFTX | DEFINIUM THERAPEUTICS INC | $94.08M | 5.60% | 2,000,000 | 0 | 0.0% | — | Unchanged |
| SYRE | SPYRE THERAPEUTICS INC | $75.18M | 4.48% | 846,786 | -1,065,594 | -55.7% | -$94.60M | Reduced |
| ANRO | ALTO NEUROSCIENCE INC | $71.87M | 4.28% | 2,723,196 | 0 | 0.0% | — | Unchanged |
| TNGX | TANGO THERAPEUTICS INC | $70.33M | 4.19% | 2,250,000 | 2,250,000 | — | $70.33M | New |
| EYPT | EYEPOINT INC | $65.78M | 3.92% | 4,600,000 | 1,775,000 | 62.8% | $25.38M | Added |
| TYRA | TYRA BIOSCIENCES INC | $59.89M | 3.57% | 1,875,000 | -600,000 | -24.2% | -$19.16M | Reduced |
| DMRA | DAMORA THERAPEUTICS INC | $50.43M | 3.00% | 1,939,000 | 0 | 0.0% | — | Unchanged |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $50.23M | 2.99% | 1,350,000 | -1,346,616 | -49.9% | -$50.11M | Reduced |
| PHVS | PHARVARIS N V | $49.28M | 2.93% | 1,425,000 | -493,970 | -25.7% | -$17.08M | Reduced |
| LBRX | LB PHARMACEUTICALS INC | $48.68M | 2.90% | 1,500,000 | 0 | 0.0% | — | Unchanged |
| ASMB | ASSEMBLY BIOSCIENCES INC | $38.88M | 2.32% | 1,415,000 | 415,000 | 41.5% | $11.40M | Added |
| EDIT | EDITAS MEDICINE INC | $28.80M | 1.72% | 8,889,000 | 8,889,000 | — | $28.80M | New |
| KYMR | KYMERA THERAPEUTICS INC | $28.67M | 1.71% | 250,000 | -500,000 | -66.7% | -$57.34M | Reduced |
| CATX | PERSPECTIVE THERAPEUTICS INC | $21.61M | 1.29% | 6,336,782 | 0 | 0.0% | — | Unchanged |
| IPSC | CENTURY THERAPEUTICS INC | $21.30M | 1.27% | 8,695,652 | 0 | 0.0% | — | Unchanged |
| ZURA | ZURA BIO LTD | $19.18M | 1.14% | 3,250,000 | 0 | 0.0% | — | Unchanged |
| AVTX | AVALO THERAPEUTICS INC | $18.82M | 1.12% | 1,018,319 | 535,319 | 110.8% | $9.89M | Added |
| IFRX | INFLARX NV | $16.35M | 0.97% | 7,300,000 | 7,300,000 | — | $16.35M | New |
| — | AN2 THERAPEUTICS INC | $14.20M | 0.85% | 2,933,680 | 599,967 | 25.7% | $2.90M | Added |
| — | NUVALENT INC | $12.35M | 0.74% | 100,000 | -733,600 | -88.0% | -$90.60M | Reduced |
| SABS | SAB BIOTHERAPEUTICS INC | $11.19M | 0.67% | 2,870,000 | -1,531,500 | -34.8% | -$5.97M | Reduced |
| IKT | INHIBIKASE THERAPEUTICS INC | $10.96M | 0.65% | 5,397,488 | 0 | 0.0% | — | Unchanged |
| RLMD | RELMADA THERAPEUTICS INC | $9.86M | 0.59% | 1,425,000 | 791,099 | 124.8% | $5.47M | Added |
| — | PEPGEN INC | $8.05M | 0.48% | 4,475,000 | 0 | 0.0% | — | Unchanged |
| — | RESEARCH ALLIANCE CORP III | $5.35M | 0.32% | 500,000 | 500,000 | — | — | First reported |
| HLXC | HELIX ACQUISITION CORP III | $5.32M | 0.32% | 500,000 | 0 | 0.0% | — | Unchanged |
| — | LEONABIO INC | $4.27M | 0.25% | 464,398 | 0 | 0.0% | — | Unchanged |
| — | VISTAGEN THERAPEUTICS INC | $630,228 | 0.04% | 2,788,620 | 2,788,620 | — | $630,228 | New |
| ERAS | ERASCA INC | $0 | 0.00% | 0 | -3,175,000 | -100.0% | -$51.37M | Sold out |
| XENE | XENON PHARMACEUTICALS INC | $0 | 0.00% | 0 | -825,000 | -100.0% | -$47.97M | Sold out |
| NRIX | NURIX THERAPEUTICS INC | $0 | 0.00% | 0 | -2,275,000 | -100.0% | -$35.26M | Sold out |
| CRVS | CORVUS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -2,258,735 | -100.0% | -$33.05M | Sold out |
| — | SOLENO THERAPEUTICS INC | $0 | 0.00% | 0 | -652,432 | -100.0% | -$21.84M | Sold out |
| OCUL | OCULAR THERAPEUTIX INC | $0 | 0.00% | 0 | -2,575,000 | -100.0% | -$21.81M | Sold out |
| PALI | PALISADE BIO INC | $0 | 0.00% | 0 | -7,181,062 | -100.0% | -$12.57M | Sold out |
| KPTI | KARYOPHARM THERAPEUTICS INC | $0 | 0.00% | 0 | -1,950,000 | -100.0% | -$10.86M | Sold out |